In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Q1: Aggressive M&A Paying Off; Oral Care Cited As Space To ‘Watch’

Executive Summary

Anglo-Dutch firm’s prestige business, created in recent years through acquisitions such as Hourglass, Dermalogica and Kate Sommerville, grew by double digits in the first quarter. Oral care declined, but CEO Alan Jope is optimistic about the segment’s future.

You may also be interested in...



Unilever’s Post-Crisis Outlook: Consumers Will Trade Down, Stay Online In Global Recession

Unilever is not providing fiscal 2020 guidance at the moment amid so many COVID-19 unknowns. However, leadership did offer predictions during the firm’s first-quarter earnings call as to how the pandemic is likely to have lasting effects on consumer behavior and the global marketplace.

Geisha-Inspired Tatcha Is Unilever's Latest US Prestige Skin-Care Addition

Unilever acquires ‘modern, prestige’ skin care firm Tatcha in a reported $500m deal. Tatcha's comprises dozens of items formulated with green tea, rice and algae. Unilever continues seeking beauty and personal care deals, which accounted for 70% of its acquired turnover in recent years.

L’Oreal Luxe Not Losing Steam In Asia; Consumer Biz Lifts On Garnier Momentum

The French cosmetics giant continues to benefit from Chinese millennials with voracious luxury appetites, posting 14% like-for-like growth in its Luxe division for the fiscal 2019 first quarter. L’Oreal’s Consumer Products business is improving as well, with a return to growth in Western Europe, while North America continues to struggle.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148761

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel